Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlycoMimetics Inc (NASDAQ:GLYC)

7.15
Delayed Data
As of Sep 30
 +0.43 / +6.40%
Today’s Change
3.70
Today|||52-Week Range
9.25
+25.00%
Year-to-Date
No recent news for GlycoMimetics Inc.

Today’s Trading

Previous close6.72
Today’s open6.73
Day’s range6.60 - 7.21
Volume114,960
Average volume (3 months)76,100
Market cap$164.9M
Dividend yield--
Data as of 4:00pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-11.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+33.56%
P/E ratioNM
Price/Sales5.42
Price/Book3.37

Competitors

 Today’s
change
Today’s
% change
MDWDMediwound Ltd-0.29-3.63%
OCULOcular Therapeutix I...+0.11+1.63%
SYNSynthetic Biologics ...-0.05-2.82%
PRQRProQR Therapeutics N...-0.08-1.19%
Data as of 4:01pm ET, 09/30/2016

Financials

Next reporting dateOctober 28, 2016
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$20.1M
Annual profit (last year)-$12.8M
Net profit margin-63.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
Chief Financial Officer
Brian M. Hahn
Corporate headquarters
Rockville, Maryland

Forecasts

Search for Jobs